The 17th Invest in ME Research International ME Conference (IIMEC17) took place on May 30, 2025, in Cambridge, United Kingdom, marking the final event of International ME Conference Week 2025—a series of collaborative events featuring workshops, strategic meetings, and scientific sessions.
As a major international forum, IIMEC17 brought together researchers, clinicians, and patient advocates dedicated to advancing research into Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS) and Long COVID.
Centered on the theme “Translating Research into Diagnostics and Treatments,” the conference highlighted the urgent need to turn scientific discoveries into clinical solutions.
OMF’s research team was proud to present some of our research projects to the conference attendees. Today, we are delighted to share recordings of the available presentations with you:
- Dr. Jonas Bergquist: Multi-Omic Biomarker Discovery for Diagnosis and Disease Mechanisms
- Dr. Wenzhong Xiao: Patient-Reported Treatment Outcomes in ME/CFS and Long COVID
- Dr. David Systrom: OMF’s Life Improvement Trial (LIFT) & Muscle Biopsy Study
- Dr. Ron Davis: Diagnostic Breakthroughs and Therapeutic Horizons for ME
If you’ve found these presentations valuable, please consider supporting OMF’s research into ME/CFS and Long COVID. Your support plays a vital role in driving scientific breakthroughs and funding essential studies like those shared at IIMEC17.
Donate your appreciated stock directly to OMF and you can receive an immediate income-tax deduction for the fair market value of the securities on the date of transfer (even if you originally paid much less for them).